Rankings
▼
Calendar
NAGE FY 2019 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$46M
+46.7% YoY
Gross Profit
$26M
55.7% margin
Operating Income
-$31M
-67.6% margin
Net Income
-$32M
-69.4% margin
EPS (Diluted)
$-0.56
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$40M
Total Liabilities
$20M
Stockholders' Equity
$20M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$46M
$32M
+46.7%
Gross Profit
$26M
$16M
+60.5%
Operating Income
-$31M
-$33M
+5.6%
Net Income
-$32M
-$33M
+3.5%
← Q4 2018
All Quarters
Q1 2019 →